We've found
2,310
archived clinical trials in
Allergy
We've found
2,310
archived clinical trials in
Allergy
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)
Updated: 9/11/2015
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR
Status: Enrolling
Updated: 9/11/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Updated: 9/28/2015
A Double-blind, Placebo-controlled, Randomized Trial to Study the Viaskin Peanut's Efficacy and Safety for Treating Peanut Allergy in Children and Adults.
Status: Enrolling
Updated: 9/28/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Updated: 10/5/2015
A Blinded, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg (Amneal Pharmaceuticals LLC) With NASONEX® Nasal Spray (Schering Corporation) in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
Updated: 10/9/2015
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Safety, Efficacy, and Tolerability Study of Two Doses of Epinastine Nasal Spray (0.05% and 0.1%) vs. Placebo in Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
Status: Enrolling
Updated: 10/21/2015
Updated: 10/21/2015
Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen
Status: Enrolling
Updated: 10/21/2015
Updated: 10/21/2015
Click here to add this to my saved trials
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
Updated: 10/28/2015
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
Status: Enrolling
Updated: 10/28/2015
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
Updated: 10/28/2015
The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis
Status: Enrolling
Updated: 10/28/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Study of Asthma and Nasal Steroids
Updated: 10/29/2015
Study of Asthma and Nasal Steroids for the American Lung Association-Airways Clinical Research Centers
Status: Enrolling
Updated: 10/29/2015
Click here to add this to my saved trials